Latest filings (excl ownership)
424B3
Prospectus supplement
22 Aug 13
EFFECT
Notice of effectiveness
21 Aug 13
25-NSE
Exchange delisting
19 Jul 13
UPLOAD
Letter from SEC
12 Jul 13
424B3
Prospectus supplement
9 Jul 13
EFFECT
Notice of effectiveness
8 Jul 13
UPLOAD
Letter from SEC
17 Apr 13
8-A12B/A
Registration of securities on exchange (amended)
3 Apr 13
424B3
Prospectus supplement
13 Dec 10
EFFECT
Notice of effectiveness
10 Dec 10
UPLOAD
Letter from SEC
30 Nov 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
424B3
Prospectus supplement
23 Apr 10
EFFECT
Notice of effectiveness
21 Apr 10
POSASR
Automatic shelf registration (post-effective amendment)
29 Mar 10
S-4
Registration of securities issued in business combination transactions
12 Feb 10
D
$100M in debt / Subsidiary Guarantees, sold $100M, 3 investors
13 Oct 09
424B5
Prospectus supplement for primary offering
6 Aug 09
424B5
Prospectus supplement for primary offering
4 Aug 09
POSASR
Automatic shelf registration (post-effective amendment)
4 Aug 09
8-A12B
Registration of securities on exchange
12 May 09
424B5
Prospectus supplement for primary offering
8 May 09
424B5
Prospectus supplement for primary offering
4 May 09
S-3ASR
Automatic shelf registration
10 Apr 09
Latest ownership filings
No filings